NEW
YORK, July 13, 2021 /PRNewswire/ -- DarioHealth
Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics
(DTx) market, announced Chief Medical Officer Omar Manejwala, M.D. will present "Rebalancing:
Digital Therapeutics in a Post-Pandemic Healthcare System" during
the virtual conference DTx Europe on July
14th at 5:55 a.m.
EST.
The theme for the DTx Europe 2021 virtual conference is Defining
the Success of Digital Therapeutics. The event brings leaders of
digital therapeutic companies, pharmaceutical companies, government
and private health care entities to foster open discussion and
learning opportunities. Dr. Manejwala's presentation offers
attendees perspective on the impacts of the pandemic going forward
and guidance on leveraging digital therapeutics for maximum impact
in a greatly changed healthcare ecosystem.
"The increased adoption of digital therapeutics during the
pandemic offered a promising view into the future of digital
therapeutics as people successfully used these solutions to manage
their health outside of the doctor's office. As we resume more
normal activities, the role of digital therapeutics should evolve
so we can more effectively address outcomes and costs for a wide
variety of conditions," said Omar
Manejwala, M.D., Chief Medical Officer, DarioHealth.
To learn more about the conference and register for the live
session, visit https://www.dtxeurope.com.
About DarioHealth Corp.
DarioHealth Corp. (Nasdaq: DRIO) is a leading global digital
therapeutics company revolutionizing how people with chronic
conditions manage their health. DarioHealth offers one of the most
comprehensive digital therapeutics solutions on the market -
covering multiple chronic conditions including diabetes,
hypertension, weight management, musculoskeletal and behavioral
health within one integrated technology platform.
Dario's next-generation, AI-powered, digital therapeutic
platform supports more than just an individual's disease. Dario
provides adaptive, personalized experiences that drive behavior
change through evidence-based interventions, intuitive, clinically
proven digital tools, high-quality software, and coaching to help
individuals improve health and sustain meaningful outcomes.
Dario's unique user-centric approach to product design and
engagement creates an unparalleled experience that is highly rated
by users and delivers sustainable results.
The company's cross-functional team operates at the intersection
of life sciences, behavioral science, and software technology and
utilizes a performance-based approach to improve its users'
health.
On the path to better health, Dario makes the right thing to do
the easy thing to do. To learn more about DarioHealth and its
digital health solutions, or for more information, visit
http://dariohealth.com.
DarioHealth Corporate Contact
Suzanne Bedell
VP
Marketing
suzanne@dariohealth.com
+1-347-767-4220
Media Contact:
Josephine Galatioto
Josephine.Galatioto@russopartnersllc.com
+1-212-845-4262
View original
content:https://www.prnewswire.com/news-releases/dariohealth-chief-medical-officer-omar-manejwala-md-to-present-on-the-role-of-digital-therapeutics-in-post-pandemic-healthcare-at-dtx-europe-301332480.html
SOURCE DarioHealth Corp.